Literature DB >> 30360809

Preparation and Controllability of Mesoporous Silica Nanoparticles.

Eisuke Yamamoto1, Kazuyuki Kuroda2.   

Abstract

Mesoporous silica nanoparticles (MSNs) have attracted great attention because of their high surface area, large pore volume, transparency, biocompatibility, and high cell-uptake efficiency. Such unique properties allow the use of these materials such as catalysts, drug carriers, and optical materials. This chapter introduces the preparation of MSNs and some recent developments in the preparation of MSNs with precisely controlled particle size, pore size, functionality, and morphology.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dispersibility; Mesoporous silica nanoparticles; Particle size

Mesh:

Substances:

Year:  2018        PMID: 30360809     DOI: 10.1016/bs.enz.2018.09.001

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  4 in total

1.  In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition.

Authors:  Seyyed Pouya Hadipour Moghaddam; Raziye Mohammadpour; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2019-08-26       Impact factor: 9.776

Review 2.  Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.

Authors:  Cristina Chircov; Angela Spoială; Cătălin Păun; Luminița Crăciun; Denisa Ficai; Anton Ficai; Ecaterina Andronescu; Ștefan Claudiu Turculeƫ
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

Review 3.  Understanding the mechanisms of silica nanoparticles for nanomedicine.

Authors:  Ziyuan Li; Yingwen Mu; Cheng Peng; Martin F Lavin; Hua Shao; Zhongjun Du
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-06-29

4.  Efficacy of Ca2+- or PO4 3--conjugated mesoporous silica nanoparticles on dentinal tubule occlusion: an in-vitro assessment.

Authors:  Tianjia Yu; Yu Wang; Qiang Cai; Lin Wu
Journal:  Ann Transl Med       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.